Daisuke Nitta
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 24, 2025
Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J-DREAMS database.Mitsuru Ohsugi, Daisuke Nitta, Yusuke Naito
|Nov 16, 2023
Empagliflozin cost-effectiveness analysis in Japanese heart failure with mildly reduced and preserved ejection fraction.Hiroyuki Tsutsui, Hiroyuki Sakamaki, Shin-Ichi Momomura
|Aug 10, 2022
Safety and effectiveness of empagliflozin and linagliptin fixed-dose combination therapy in Japanese patients with type 2 diabetes: final results of a one-year post-marketing surveillance study.Nobuya Inagaki, Takaaki Nishimoto, Yoichi Nishiya
|Apr 05, 2022
Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study.Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima
Pageof 1
